Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 58.60% is 217% above its 5-year average of 18.48%, near the high end of its 5-year range (-255.30%–58.60%).
As of the fiscal period ended Tuesday, June 30, 2026. 114.52% above its 12-month average of 27.32%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 58.60%.
RETURN ON INVESTED CAPITAL (ROIC)
58.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
27.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-52.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
18.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
10.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-14.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+114.52%
CURRENT VS 3Y AVG
+212.45%
CURRENT VS 5Y AVG
+217.17%
CURRENT VS 10Y AVG
+449.14%
CURRENT VS 15Y AVG
+493.97%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.10%
median of 589 covered companies
CURRENT VS SECTOR MEDIAN
+271.86%
vs the sector median at left
Ironwood Pharmaceuticals, Inc.
Market Cap
$595.08M
Return on Invested Capital (ROIC)
58.60%
TTM Avg
27.32%
3Y Avg
-52.11%
5Y Avg
18.48%
Market Cap
$603.91M
Return on Invested Capital (ROIC)
-11.80%
TTM Avg
-7.26%
3Y Avg
-5.22%
5Y Avg
9.70%
Market Cap
$611.51M
Return on Invested Capital (ROIC)
-20.75%
TTM Avg
-20.15%
3Y Avg
-33.64%
5Y Avg
-24.57%
Market Cap
$581.51M
Return on Invested Capital (ROIC)
-4.97%
TTM Avg
-6.49%
3Y Avg
-6.53%
5Y Avg
-6.86%
Market Cap
$569.61M
Return on Invested Capital (ROIC)
-47.96%
TTM Avg
-47.20%
3Y Avg
-41.20%
5Y Avg
-37.18%
Market Cap
$624.74M
Return on Invested Capital (ROIC)
-26.94%
TTM Avg
-40.40%
3Y Avg
-38.31%
5Y Avg
-45.27%
Market Cap
$562.50M
Return on Invested Capital (ROIC)
27.87%
TTM Avg
-1.63%
3Y Avg
-31.88%
5Y Avg
-39.02%
Market Cap
$562.09M
Return on Invested Capital (ROIC)
-45.62%
TTM Avg
-46.61%
3Y Avg
-61.97%
5Y Avg
-71.18%
Market Cap
$560.00M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. (IRWD) | $595.08M | 58.60% | 27.32% | -52.11% | 18.48% |
| Fulgent Genetics, Inc. (FLGT)vs › | $603.91M | -11.80% | -7.26% | -5.22% | 9.70% |
| AngioDynamics, Inc. (ANGO)vs › | $611.51M | -20.75% | -20.15% | -33.64% | -24.57% |
| OrthoPediatrics Corp. (KIDS)vs › | $581.51M | -4.97% | -6.49% | -6.53% | -6.86% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $569.61M | -47.96% | -47.20% | -41.20% | -37.18% |
| Climb Bio, Inc. (CLYM)vs › | $624.74M | -26.94% | -40.40% | -38.31% | -45.27% |
| CorMedix Inc. (CRMD)vs › | $562.50M | 27.87% | -1.63% | -31.88% | -39.02% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $562.09M | -45.62% | -46.61% | -61.97% | -71.18% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $633.55M | -42.02% | -66.01% | -48.82% | -55.42% |
ROIC
58.6%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 58.60% |
| 2026-03-31 | 29.97% |
| 2025-12-31 | 15.55% |
| 2025-09-30 | 19.49% |
| 2025-06-30 | 12.98% |
| 2025-03-31 | 10.32% |
| 2024-12-31 | 16.41% |
| 2024-09-30 | 15.90% |
| 2024-06-30 | 19.02% |
| 2024-03-31 | -255.30% |
| 2023-12-31 | -237.46% |
| 2023-09-30 | -204.62% |
| 2023-06-30 | -178.34% |
| 2023-03-31 | 15.47% |
| 2022-12-31 | 16.15% |
| 2022-09-30 | 17.37% |
| 2022-06-30 | 19.72% |
| 2022-03-31 | 23.16% |
| 2021-12-31 | 21.46% |
| 2021-09-30 | 21.59% |
| 2021-06-30 | 21.05% |
| 2021-03-31 | 29.60% |
| 2020-12-31 | 26.30% |
| 2020-09-30 | 30.14% |
| 2020-06-30 | 38.48% |
| 2020-03-31 | 39.73% |
| 2019-12-31 | 12.66% |
| 2019-09-30 | 13.88% |
| 2019-06-30 | -77.23% |
| 2019-03-31 | -88.47% |
| 2018-12-31 | -91.85% |
| 2018-09-30 | -64.71% |
| 2018-06-30 | -13.22% |
| 2018-03-31 | -14.12% |
| 2017-12-31 | -14.34% |
| 2017-09-30 | -18.99% |
| 2017-06-30 | -18.45% |
| 2017-03-31 | -14.40% |
| 2016-12-31 | -8.38% |
| 2016-09-30 | -7.92% |
| 2016-06-30 | -7.65% |
| 2016-03-31 | -13.73% |
| 2015-12-31 | -17.99% |
| 2015-09-30 | -22.87% |
| 2015-06-30 | -22.96% |
| 2015-03-31 | -59.11% |
| 2014-12-31 | -59.59% |
| 2014-09-30 | -60.70% |
| 2014-06-30 | -60.35% |
| 2014-03-31 | -53.95% |
| 2013-12-31 | -105.92% |
| 2013-09-30 | -87.08% |
| 2013-06-30 | -42.64% |
| 2013-03-31 | -48.00% |
| 2012-12-31 | -41.59% |
| 2012-09-30 | -17.02% |
| 2012-06-30 | -65.89% |
| 2012-03-31 | -42.27% |
| 2011-12-31 | -45.98% |
| 2011-09-30 | -48.38% |
| 2011-06-30 | -37.15% |
| 2011-03-31 | -30.65% |
| 2010-12-31 | -26.38% |
| 2010-09-30 | -29.67% |
| 2010-06-30 | -24.81% |
| 2010-03-31 | -23.63% |
| 2009-12-31 | -65.05% |
| 2009-09-30 | -57.03% |
